Lopinavir Completed Phase N/A Trials for Lipodystrophies / Wasting Disease / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00357552Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
NCT00255840Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities
NCT00414518Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
NCT00413153Metabolic Effects of Switching Kaletra to Boosted Reyataz
NCT00762320Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
NCT00080522Strategies for Delivering Anti-HIV Therapy in South Africa
NCT00100646Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
NCT00102986Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
NCT00034086Study of Anti-HIV Therapy Intensification
NCT00014937Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
NCT00028366Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
NCT00028314Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
NCT00004855Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs